Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients
Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients - a Randomized Trial
調査の概要
詳細な説明
Seriously sick people need social support to maintain their quality of life. Social support may be given by peers, who have experienced the same.
In this study voluntary participants with recently diagnosed breast cancer were randomly allocated to intervention (N=130) or control (N=130) group. The intervention group received, in addition to usual care, peer support via telephone 1-5 times according to their own preference. The control group received usual care only. Peer support was given by volunteered breast cancer survivors who were educated for giving peer support.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Helsinki、フィンランド、00029
- Helsinki University Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- recently diagnosed primary breast cancer
- no other serious illnesses
- ability to communicate in Finnish or Swedish (official languages in Finland)
- ability to fill in the questionnaires
Exclusion Criteria:
- some other serious illnesses
- inability to communicate in Finnish or Swedish (official languages in Finland)
- inability to fill in the questionnaires
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Intervention group
Peer support group received, in addition to usual care, peer support via telephone 1-5 times according to their own preference.
Peer support was started at the time between diagnosis and the beginning of treatments.
|
Peer support persons are breast cancer survivors, who were educated to give peer support.
They contacted participants by telephone.
|
|
介入なし:Control group
The control group received usual care only.
For ethical reasons, participants in the control group were not discouraged from seeking peer support by themselves if they felt a need for it.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
A change of health-related quality of life (HRQoL).
時間枠:From baseline to 3, 6 and 12 months later.
|
HRQoL was assessed with a generic 15D instrument.
|
From baseline to 3, 6 and 12 months later.
|
|
A change of health-related quality of life (HRQoL).
時間枠:From baseline to 3, 6 and 12 months later.
|
HRQoL was assessed with a disease-specific instrument EORTC QLQ-30 and its breast cancer specific module BR23.
|
From baseline to 3, 6 and 12 months later.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Satisfaction for life
時間枠:Baseline and 3, 6 and 12 months later.
|
Satisfaction for life was assessed with a questionnaire created for this study.
|
Baseline and 3, 6 and 12 months later.
|
|
The use of health care services
時間枠:Baseline and 3, 6 and 12 months later.
|
The use of health care services was assessed with a questionnaire create for this study.
|
Baseline and 3, 6 and 12 months later.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Anu Toija, MHS、University of Jyväskylä
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。